CITALOPRAM HYDROBROMIDE

CITALOPRAM HYDROBROMIDE was reported 107736 times

CITALOPRAM HYDROBROMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TEMPERATURE REGULATION DISORDER 565 0.2534
1 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 171 0.2475
2 CARDIOSPASM 79 0.1416
3 DISINHIBITION 213 0.1322
4 AGITATION NEONATAL 126 0.1314
5 RESPIRATORY DISORDER NEONATAL 201 0.1239
6 STEROID DEPENDENCE 107 0.1219
7 CATARRH 104 0.1150
8 PALMOPLANTAR KERATODERMA 79 0.1090
9 PSYCHIATRIC DECOMPENSATION 189 0.0966
10 ANORGASMIA 227 0.0835
11 DISTURBANCE IN SEXUAL AROUSAL 76 0.0826
12 GENITAL HYPOAESTHESIA 83 0.0813
13 ACCIDENTAL DEATH 145 0.0781
14 FOOD ALLERGY 600 0.0777
15 SEROTONIN SYNDROME 1420 0.0739
16 DEPRESSIVE SYMPTOM 245 0.0694
17 TEARFULNESS 291 0.0676
18 DEPRESSION SUICIDAL 226 0.0652
19 ALCOHOL POISONING 172 0.0642
20 PSYCHOMOTOR SKILLS IMPAIRED 167 0.0637
21 BRADYCARDIA NEONATAL 80 0.0636
22 BURNS SECOND DEGREE 111 0.0632
23 FOETAL DEATH 312 0.0601
24 SMALL FOR DATES BABY 285 0.0574
25 LONG QT SYNDROME 131 0.0546
26 BLOOD PRESSURE SYSTOLIC ABNORMAL 133 0.0538
27 MULTIPLE DRUG OVERDOSE 259 0.0521
28 HYPERREFLEXIA 180 0.0516
29 MULTIPLE DRUG OVERDOSE INTENTIONAL 164 0.0509
30 COMPLETED SUICIDE 4228 0.0507
31 COELIAC DISEASE 479 0.0488
32 TORSADE DE POINTES 383 0.0488
33 NEPHROGENIC ANAEMIA 226 0.0487
34 BLOOD PRESSURE DIASTOLIC ABNORMAL 124 0.0487
35 BRUXISM 260 0.0482
36 ATRIAL TACHYCARDIA 101 0.0480
37 ALCOHOL INTERACTION 93 0.0478
38 ELECTROCARDIOGRAM QT PROLONGED 1634 0.0454
39 COMA SCALE ABNORMAL 130 0.0448
40 HYPERPARATHYROIDISM SECONDARY 111 0.0443
41 HYPOSPADIAS 91 0.0437
42 PSYCHOMOTOR RETARDATION 122 0.0434
43 IMMUNODEFICIENCY 642 0.0430
44 BURSITIS 522 0.0430
45 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 220 0.0429
46 EMOTIONAL POVERTY 75 0.0428
47 NEONATAL RESPIRATORY DISTRESS SYNDROME 151 0.0426
48 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 83 0.0420
49 CLONUS 114 0.0416
50 REBOUND ACID HYPERSECRETION 126 0.0416
51 SOPOR 545 0.0411
52 OBSESSIVE-COMPULSIVE DISORDER 329 0.0410
53 HYPOPNOEA 142 0.0409
54 THERAPEUTIC PRODUCT EFFECT VARIABLE 158 0.0407
55 EXPOSURE VIA INGESTION 101 0.0400
56 POISONING 490 0.0390
57 TACHYPHRENIA 130 0.0375
58 PULSELESS ELECTRICAL ACTIVITY 155 0.0371
59 DYSLIPIDAEMIA 188 0.0370
60 PRURITUS GENITAL 86 0.0365
61 ATRIAL SEPTAL DEFECT 304 0.0363
62 ALCOHOL ABUSE 95 0.0355
63 LABYRINTHITIS 89 0.0352
64 MATERNAL DRUGS AFFECTING FOETUS 268 0.0349
65 VENTRICULAR SEPTAL DEFECT 200 0.0349
66 ANGLE CLOSURE GLAUCOMA 88 0.0345
67 ALCOHOL USE 126 0.0341
68 DRUG TOXICITY 460 0.0337
69 LOSS OF LIBIDO 303 0.0337
70 PERSONALITY DISORDER 88 0.0336
71 SUSPECTED SUICIDE 157 0.0335
72 MYOCLONUS 395 0.0331
73 DRUG ABUSE 2742 0.0329
74 OSTEITIS 83 0.0329
75 AKATHISIA 447 0.0327
76 PRESCRIBED OVERDOSE 632 0.0326
77 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 335 0.0326
78 PARKINSONISM 318 0.0326
79 FLAT AFFECT 74 0.0319
80 SELF-INJURIOUS IDEATION 134 0.0319
81 YAWNING 85 0.0318
82 INTENTIONAL SELF-INJURY 639 0.0316
83 TENSION HEADACHE 135 0.0314
84 BRONCHIECTASIS 211 0.0313
85 SEXUAL DYSFUNCTION 366 0.0312
86 TOXICITY TO VARIOUS AGENTS 5192 0.0308
87 HYPOMANIA 110 0.0299
88 STUPOR 95 0.0295
89 CAROTID ARTERY OCCLUSION 107 0.0293
90 MUSCLE RIGIDITY 350 0.0292
91 HYPONATRAEMIA 1645 0.0292
92 LOOSE TOOTH 94 0.0291
93 BRADYKINESIA 172 0.0291
94 ACCIDENTAL OVERDOSE 1062 0.0290
95 SLEEP TERROR 121 0.0287
96 HOSTILITY 73 0.0287
97 IMPULSIVE BEHAVIOUR 105 0.0280
98 RESPIRATORY ARREST 767 0.0278
99 SUICIDE ATTEMPT 1661 0.0274
100 MYDRIASIS 346 0.0269
101 ELECTRIC SHOCK SENSATION 75 0.0268
102 RHINITIS 216 0.0268
103 ATRIOVENTRICULAR BLOCK FIRST DEGREE 115 0.0265
104 SUICIDAL BEHAVIOUR 110 0.0264
105 DRUG INTERACTION 4178 0.0263
106 OBESITY 419 0.0263
107 ANTIPSYCHOTIC DRUG LEVEL INCREASED 74 0.0263
108 ALCOHOLISM 111 0.0259
109 PARANOIA 445 0.0258
110 GESTATIONAL DIABETES 123 0.0258
111 INTENTIONAL OVERDOSE 1652 0.0257
112 BRADYPHRENIA 168 0.0257
113 HALLUCINATIONS, MIXED 108 0.0257
114 HYPERTONIC BLADDER 73 0.0253
115 POTENTIATING DRUG INTERACTION 84 0.0250
116 HOMICIDAL IDEATION 101 0.0249
117 FINE MOTOR SKILL DYSFUNCTION 72 0.0249
118 CARDIO-RESPIRATORY ARREST 1038 0.0248
119 MUSCLE TWITCHING 558 0.0242
120 LEFT VENTRICULAR HYPERTROPHY 101 0.0236
121 PATENT DUCTUS ARTERIOSUS 93 0.0234
122 HYPERTONIA 134 0.0234
123 HYPERVENTILATION 135 0.0233
124 MAJOR DEPRESSION 169 0.0231
125 LOGORRHOEA 81 0.0230
126 RESPIRATORY ACIDOSIS 89 0.0226
127 UNRESPONSIVE TO STIMULI 583 0.0226
128 EUPHORIC MOOD 230 0.0224
129 SUICIDAL IDEATION 2047 0.0223
130 PAROSMIA 168 0.0222
131 CATATONIA 116 0.0221
132 CONCUSSION 171 0.0221
133 RESTLESSNESS 808 0.0221
134 SINUS TACHYCARDIA 312 0.0220
135 VENTRICULAR ARRHYTHMIA 80 0.0219
136 PANIC DISORDER 84 0.0217
137 DYSPHEMIA 94 0.0214
138 PANIC REACTION 153 0.0212
139 CEREBRAL ATROPHY 84 0.0211
140 PSYCHOTIC DISORDER 618 0.0209
141 END STAGE RENAL DISEASE 381 0.0209
142 ASPHYXIA 170 0.0208
143 AGITATION 1528 0.0208
144 BLOOD PRESSURE DIASTOLIC INCREASED 96 0.0208
145 APATHY 303 0.0208
146 CIRCULATORY COLLAPSE 351 0.0206
147 BLOOD PRESSURE SYSTOLIC INCREASED 398 0.0204
148 VENTRICULAR TACHYCARDIA 336 0.0203
149 ORTHOSTATIC HYPOTENSION 353 0.0203
150 HALLUCINATION, VISUAL 421 0.0199
151 SNORING 75 0.0198
152 GINGIVAL PAIN 157 0.0197
153 UPPER RESPIRATORY TRACT INFECTION 908 0.0196
154 NEUROLEPTIC MALIGNANT SYNDROME 233 0.0196
155 GRAND MAL CONVULSION 181 0.0196
156 HALLUCINATION, AUDITORY 307 0.0193
157 PRE-EXISTING CONDITION IMPROVED 120 0.0192
158 FULL BLOOD COUNT ABNORMAL 203 0.0192
159 RESTLESS LEGS SYNDROME 349 0.0192
160 SEDATION 502 0.0191
161 BUNDLE BRANCH BLOCK LEFT 81 0.0191
162 TUBULOINTERSTITIAL NEPHRITIS 356 0.0190
163 PANIC ATTACK 687 0.0188
164 SUBSTANCE ABUSE 153 0.0188
165 SOCIAL AVOIDANT BEHAVIOUR 108 0.0186
166 DISTURBANCE IN ATTENTION 998 0.0185
167 NIGHTMARE 640 0.0185
168 RESPIRATORY RATE INCREASED 164 0.0185
169 NYSTAGMUS 98 0.0184
170 HYPOTONIA 184 0.0184
171 DRUG LEVEL ABOVE THERAPEUTIC 84 0.0183
172 POST-TRAUMATIC STRESS DISORDER 122 0.0182
173 CONTRAINDICATED PRODUCT ADMINISTERED 549 0.0181
174 GOITRE 74 0.0181
175 DEPRESSED LEVEL OF CONSCIOUSNESS 712 0.0180
176 CHRONIC KIDNEY DISEASE 1367 0.0180
177 DISORIENTATION 712 0.0179
178 SUBARACHNOID HAEMORRHAGE 183 0.0179
179 CARDIAC MURMUR 155 0.0179
180 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 158 0.0179
181 PERSONALITY CHANGE 166 0.0179
182 HEPATIC STEATOSIS 332 0.0178
183 URINE ABNORMALITY 81 0.0178
184 CARDIOMEGALY 218 0.0177
185 INTERVERTEBRAL DISC DISORDER 75 0.0175
186 DELUSION 271 0.0174
187 HYPERHIDROSIS 2246 0.0174
188 ACIDOSIS 133 0.0174
189 FOETAL EXPOSURE DURING PREGNANCY 1414 0.0174
190 OBSTRUCTIVE AIRWAYS DISORDER 193 0.0173
191 COORDINATION ABNORMAL 242 0.0173
192 FOOT DEFORMITY 192 0.0173
193 ANGIOPATHY 97 0.0173
194 BUNDLE BRANCH BLOCK RIGHT 79 0.0172
195 ATELECTASIS 166 0.0172
196 HYPERTHERMIA 131 0.0171
197 DECREASED INTEREST 101 0.0171
198 OVERWEIGHT 92 0.0171
199 RENAL CYST 136 0.0171
200 SLEEP APNOEA SYNDROME 326 0.0171
201 SOMNAMBULISM 112 0.0170
202 COGNITIVE DISORDER 791 0.0169
203 BRAIN INJURY 169 0.0168
204 DEPRESSED MOOD 885 0.0167
205 DYSKINESIA 680 0.0167
206 FEELING OF DESPAIR 78 0.0167
207 CONFUSIONAL STATE 2699 0.0167
208 PULMONARY CONGESTION 220 0.0167
209 CARDIAC ARREST 1374 0.0166
210 ERECTILE DYSFUNCTION 426 0.0166
211 SPUTUM DISCOLOURED 157 0.0165
212 PSYCHIATRIC SYMPTOM 122 0.0165
213 INCREASED APPETITE 315 0.0165
214 RASH ERYTHEMATOUS 788 0.0165
215 DELIRIUM 569 0.0164
216 AGGRESSION 817 0.0163
217 HAEMATEMESIS 413 0.0163
218 HYPOKALAEMIA 751 0.0163
219 TENSION 99 0.0162
220 RESPIRATORY DEPRESSION 199 0.0162
221 MANIA 267 0.0162
222 INCONTINENCE 171 0.0162
223 DRUG LEVEL INCREASED 267 0.0161
224 MELAENA 355 0.0161
225 ABDOMINAL TENDERNESS 80 0.0161
226 WITHDRAWAL SYNDROME 676 0.0161
227 ATAXIA 191 0.0161
228 TRISMUS 83 0.0161
229 ARTERIOSCLEROSIS CORONARY ARTERY 106 0.0160
230 DEPRESSION 3600 0.0158
231 HYPOKINESIA 227 0.0156
232 INCOHERENT 101 0.0156
233 FACIAL PAIN 139 0.0156
234 BLOOD PRESSURE DIASTOLIC DECREASED 114 0.0154
235 NEUTROPHIL COUNT INCREASED 158 0.0154
236 PSYCHOLOGICAL TRAUMA 132 0.0153
237 DEMENTIA 427 0.0153
238 GALACTORRHOEA 98 0.0152
239 UPPER GASTROINTESTINAL HAEMORRHAGE 256 0.0152
240 ON AND OFF PHENOMENON 84 0.0151
241 MEDICATION ERROR 840 0.0151
242 TOOTH FRACTURE 166 0.0150
243 BLOOD PRESSURE FLUCTUATION 360 0.0150
244 HALLUCINATION 1130 0.0150
245 ASPIRATION 164 0.0150
246 THINKING ABNORMAL 279 0.0150
247 BRADYCARDIA 792 0.0149
248 HIATUS HERNIA 193 0.0149
249 PELVIC FRACTURE 116 0.0149
250 VENTRICULAR FIBRILLATION 164 0.0148
251 MIOSIS 118 0.0147
252 PSYCHOMOTOR HYPERACTIVITY 244 0.0147
253 FEELING OF BODY TEMPERATURE CHANGE 86 0.0147
254 DRUG WITHDRAWAL SYNDROME NEONATAL 217 0.0146
255 BRAIN OEDEMA 185 0.0146
256 URINARY RETENTION 485 0.0145
257 POOR QUALITY SLEEP 312 0.0145
258 COMA 689 0.0145
259 AFFECTIVE DISORDER 113 0.0144
260 HYPOMAGNESAEMIA 200 0.0144
261 FLUID RETENTION 728 0.0143
262 TREMOR 2363 0.0142
263 DYSARTHRIA 532 0.0141
264 EXPOSURE DURING PREGNANCY 878 0.0141
265 IMPAIRED QUALITY OF LIFE 203 0.0141
266 ANAL INCONTINENCE 127 0.0141
267 ANXIETY 3998 0.0140
268 ANHEDONIA 367 0.0140
269 DISSOCIATION 107 0.0139
270 RALES 81 0.0139
271 MENTAL IMPAIRMENT 338 0.0139
272 SALIVARY HYPERSECRETION 139 0.0139
273 ELECTROCARDIOGRAM ABNORMAL 109 0.0139
274 ELECTROLYTE IMBALANCE 161 0.0138
275 MICTURITION URGENCY 158 0.0138
276 SPINAL PAIN 162 0.0138
277 POISONING DELIBERATE 131 0.0138
278 AMNESIA 895 0.0137
279 DUODENAL ULCER 97 0.0137
280 FREQUENT BOWEL MOVEMENTS 368 0.0136
281 MUSCLE SPASTICITY 167 0.0136
282 INITIAL INSOMNIA 139 0.0135
283 HEPATIC ENZYME INCREASED 922 0.0135
284 FALL 4497 0.0135
285 BODY TEMPERATURE DECREASED 133 0.0135
286 ABNORMAL DREAMS 373 0.0135
287 TACHYCARDIA 1198 0.0135
288 MOTOR DYSFUNCTION 137 0.0134
289 ANAL FISSURE 72 0.0134
290 URINARY INCONTINENCE 397 0.0134
291 HEART RATE DECREASED 470 0.0134
292 IMPAIRED WORK ABILITY 286 0.0134
293 DECREASED IMMUNE RESPONSIVENESS 131 0.0133
294 SINUS BRADYCARDIA 129 0.0133
295 INCREASED TENDENCY TO BRUISE 122 0.0132
296 BLOOD CALCIUM DECREASED 148 0.0131
297 DRUG SCREEN POSITIVE 104 0.0131
298 MENTAL STATUS CHANGES 365 0.0131
299 HAEMODYNAMIC INSTABILITY 100 0.0131
300 IRON DEFICIENCY ANAEMIA 121 0.0131
301 FEELING DRUNK 97 0.0130
302 ANGER 441 0.0130
303 LEUKAEMIA 123 0.0130
304 CHOLECYSTITIS CHRONIC 87 0.0130
305 TINNITUS 597 0.0130
306 APPETITE DISORDER 86 0.0130
307 IRRITABILITY 780 0.0130
308 BALANCE DISORDER 1118 0.0129
309 SYNCOPE 1292 0.0129
310 PHOTOSENSITIVITY REACTION 213 0.0129
311 BODY TEMPERATURE INCREASED 263 0.0129
312 NEUTROPENIC SEPSIS 92 0.0129
313 SWOLLEN TONGUE 402 0.0129
314 ARTERIOSCLEROSIS 121 0.0128
315 PNEUMONIA ASPIRATION 321 0.0128
316 PERONEAL NERVE PALSY 73 0.0128
317 SENSORY DISTURBANCE 206 0.0128
318 APHASIA 387 0.0128
319 HYPERLIPIDAEMIA 153 0.0128
320 DIZZINESS POSTURAL 124 0.0128
321 OVERDOSE 2754 0.0128
322 SKIN WARM 74 0.0127
323 SOMNOLENCE 2556 0.0127
324 BIPOLAR DISORDER 138 0.0127
325 RIB FRACTURE 261 0.0127
326 BLOOD MAGNESIUM DECREASED 109 0.0126
327 BLOOD ALBUMIN DECREASED 100 0.0126
328 SLEEP DISORDER 889 0.0126
329 APNOEA 98 0.0126
330 METABOLIC ACIDOSIS 402 0.0126
331 HYPERSOMNIA 360 0.0125
332 CAESAREAN SECTION 146 0.0125
333 HYPOGLYCAEMIA 608 0.0125
334 INTERNATIONAL NORMALISED RATIO INCREASED 357 0.0125
335 MYOCARDIAL ISCHAEMIA 142 0.0125
336 DYSTONIA 242 0.0125
337 MUSCULOSKELETAL CHEST PAIN 193 0.0125
338 UROSEPSIS 115 0.0125
339 LACERATION 117 0.0124
340 INTENTIONAL DRUG MISUSE 260 0.0124
341 ASTHMA 1403 0.0124
342 BLOOD CREATINE PHOSPHOKINASE INCREASED 357 0.0124
343 HEAD INJURY 392 0.0124
344 OESOPHAGITIS 135 0.0123
345 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 76 0.0123
346 ECONOMIC PROBLEM 186 0.0123
347 OXYGEN SATURATION DECREASED 688 0.0122
348 OSTEOARTHRITIS 518 0.0122
349 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 637 0.0122
350 HYPERPROLACTINAEMIA 79 0.0122
351 LOSS OF CONSCIOUSNESS 1560 0.0122
352 MUSCLE TIGHTNESS 197 0.0121
353 RECTAL HAEMORRHAGE 521 0.0121
354 CARDIOTOXICITY 108 0.0121
355 PULMONARY OEDEMA 542 0.0121
356 PURPURA 107 0.0121
357 LETHARGY 693 0.0120
358 RETCHING 256 0.0120
359 SUDDEN DEATH 127 0.0120
360 VITAMIN D DEFICIENCY 117 0.0120
361 APHTHOUS ULCER 93 0.0120
362 BLOOD SODIUM DECREASED 226 0.0120
363 BLADDER DISORDER 119 0.0120
364 LIVER FUNCTION TEST ABNORMAL 348 0.0120
365 RENAL INJURY 353 0.0119
366 GASTROENTERITIS 173 0.0118
367 RHABDOMYOLYSIS 493 0.0118
368 VERTIGO 720 0.0118
369 TENDERNESS 123 0.0118
370 HYPERKALAEMIA 413 0.0118
371 HYPOTHERMIA 119 0.0117
372 INTENTIONAL PRODUCT MISUSE 1023 0.0117
373 SKIN LACERATION 126 0.0116
374 TROPONIN INCREASED 88 0.0116
375 RHEUMATOID ARTHRITIS 1312 0.0115
376 DRUG USE DISORDER 97 0.0115
377 AFFECT LABILITY 111 0.0115
378 FLANK PAIN 108 0.0115
379 BODY HEIGHT DECREASED 123 0.0115
380 GROIN PAIN 101 0.0115
381 VENTRICULAR EXTRASYSTOLES 119 0.0114
382 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 550 0.0114
383 ACUTE KIDNEY INJURY 1749 0.0114
384 GENERALISED TONIC-CLONIC SEIZURE 189 0.0114
385 VASCULITIS 133 0.0114
386 SPINAL OSTEOARTHRITIS 100 0.0114
387 MOOD SWINGS 362 0.0113
388 JOINT DISLOCATION 120 0.0113
389 WHEEZING 673 0.0113
390 EMPHYSEMA 114 0.0113
391 LEUKOPENIA 564 0.0113
392 SPEECH DISORDER 588 0.0112
393 INFUSION RELATED REACTION 741 0.0112
394 EXTRASYSTOLES 78 0.0112
395 ABORTION INDUCED 105 0.0111
396 INTERVERTEBRAL DISC DEGENERATION 103 0.0111
397 RENAL TUBULAR NECROSIS 109 0.0111
398 ECCHYMOSIS 76 0.0111
399 ATRIOVENTRICULAR BLOCK COMPLETE 74 0.0110
400 DERMATITIS ALLERGIC 139 0.0110
401 MOVEMENT DISORDER 354 0.0110
402 LIGAMENT SPRAIN 109 0.0110
403 LOWER RESPIRATORY TRACT INFECTION 501 0.0110
404 CONVULSION 630 0.0110
405 PLATELET COUNT INCREASED 143 0.0110
406 LIP SWELLING 365 0.0109
407 DIPLOPIA 284 0.0109
408 NEPHROPATHY 102 0.0109
409 UPPER-AIRWAY COUGH SYNDROME 90 0.0109
410 MENTAL DISORDER 475 0.0109
411 VITAMIN D DECREASED 93 0.0109
412 HEMIPARESIS 184 0.0109
413 MEMORY IMPAIRMENT 1491 0.0108
414 DEFAECATION URGENCY 76 0.0108
415 DYSPNOEA EXERTIONAL 408 0.0108
416 GASTRITIS 285 0.0108
417 EXTRAPYRAMIDAL DISORDER 268 0.0108
418 SUBDURAL HAEMATOMA 154 0.0107
419 ATRIOVENTRICULAR BLOCK 83 0.0107
420 GAMMA-GLUTAMYLTRANSFERASE INCREASED 237 0.0107
421 VISUAL FIELD DEFECT 77 0.0106
422 URINE OUTPUT DECREASED 93 0.0106
423 MITRAL VALVE INCOMPETENCE 120 0.0106
424 RENAL FAILURE 1407 0.0106
425 CHOLECYSTECTOMY 121 0.0106
426 TRANSIENT ISCHAEMIC ATTACK 357 0.0106
427 HAEMATOMA 274 0.0106
428 GENERAL PHYSICAL HEALTH DETERIORATION 1220 0.0105
429 CYSTITIS 334 0.0105
430 JOINT SWELLING 1266 0.0105
431 CONSTIPATION 2285 0.0105
432 HAEMATOCHEZIA 577 0.0104
433 ENCEPHALOPATHY 256 0.0104
434 HYPERCHOLESTEROLAEMIA 100 0.0103
435 NIGHT SWEATS 332 0.0103
436 FEAR 277 0.0103
437 ABNORMAL BEHAVIOUR 407 0.0103
438 CHOLELITHIASIS 336 0.0102
439 CANDIDA INFECTION 173 0.0102
440 DRY MOUTH 831 0.0102
441 MIDDLE INSOMNIA 191 0.0102
442 SKIN PLAQUE 86 0.0102
443 WHITE BLOOD CELL COUNT INCREASED 390 0.0102
444 ARRHYTHMIA 481 0.0101
445 THIRST 181 0.0101
446 CONTUSION 975 0.0101
447 GASTROOESOPHAGEAL REFLUX DISEASE 814 0.0101
448 HYPOTENSION 2015 0.0100
449 LYMPHOCYTE COUNT DECREASED 177 0.0100
450 HIP FRACTURE 322 0.0100
451 EPILEPSY 306 0.0100
452 PRODUCTIVE COUGH 477 0.0100
453 JOINT RANGE OF MOTION DECREASED 134 0.0100
454 HEPATIC ENCEPHALOPATHY 93 0.0100
455 HAIR DISORDER 82 0.0099
456 CONGENITAL ANOMALY 77 0.0099
457 BLOOD IRON DECREASED 118 0.0099
458 HYPERTENSION 2106 0.0099
459 DYSSTASIA 290 0.0099
460 QUALITY OF LIFE DECREASED 133 0.0099
461 POOR VENOUS ACCESS 102 0.0098
462 RED BLOOD CELL SEDIMENTATION RATE INCREASED 109 0.0098
463 INTERVERTEBRAL DISC PROTRUSION 215 0.0098
464 SEASONAL ALLERGY 139 0.0098
465 HYPOPHAGIA 251 0.0098
466 PALLOR 267 0.0098
467 PALPITATIONS 1148 0.0098
468 ACCIDENT 117 0.0098
469 PREGNANCY 196 0.0098
470 INSOMNIA 2605 0.0098
471 WRIST FRACTURE 117 0.0098
472 MOBILITY DECREASED 700 0.0097
473 DEEP VEIN THROMBOSIS 633 0.0097
474 FACIAL PARALYSIS 83 0.0097
475 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 165 0.0097
476 BLOOD POTASSIUM DECREASED 292 0.0097
477 URINARY TRACT INFECTION 1656 0.0097
478 SENSORY LOSS 78 0.0097
479 HEAD DISCOMFORT 171 0.0096
480 BACK PAIN 2243 0.0096
481 JOINT STIFFNESS 253 0.0096
482 MOOD ALTERED 263 0.0096
483 OSTEOPOROSIS 396 0.0096
484 RENAL FAILURE CHRONIC 74 0.0096
485 ANOSMIA 139 0.0096
486 MIGRAINE 916 0.0096
487 BLOOD UREA INCREASED 160 0.0095
488 HYPOXIA 336 0.0095
489 ANURIA 82 0.0095
490 RENAL FAILURE ACUTE 404 0.0095
491 SECRETION DISCHARGE 119 0.0095
492 ACTIVITIES OF DAILY LIVING IMPAIRED 188 0.0095
493 WEIGHT INCREASED 2121 0.0095
494 EAR INFECTION 251 0.0094
495 ANKLE FRACTURE 146 0.0094
496 GASTRIC ULCER 179 0.0094
497 SCIATICA 150 0.0094
498 BLOOD PRESSURE DECREASED 625 0.0094
499 RESPIRATORY FAILURE 685 0.0094
500 HAEMATOCRIT DECREASED 186 0.0094
501 TYPE 2 DIABETES MELLITUS 315 0.0093
502 CLOSTRIDIUM DIFFICILE COLITIS 99 0.0093
503 BRAIN FOG 144 0.0092
504 BLOOD POTASSIUM INCREASED 149 0.0092
505 PRESYNCOPE 223 0.0092
506 BLOOD COUNT ABNORMAL 139 0.0092
507 HAEMORRHAGE INTRACRANIAL 137 0.0092
508 HAIR COLOUR CHANGES 114 0.0092
509 MUSCULAR WEAKNESS 1041 0.0092
510 THROMBOCYTOPENIA 1023 0.0091
511 TOOTH INFECTION 120 0.0091
512 FATIGUE 7087 0.0091
513 FEELING COLD 253 0.0091
514 ORAL PAIN 203 0.0091
515 MOUTH ULCERATION 191 0.0091
516 TACHYPNOEA 123 0.0090
517 IMPAIRED GASTRIC EMPTYING 123 0.0090
518 FOOT FRACTURE 171 0.0090
519 ALTERED STATE OF CONSCIOUSNESS 195 0.0090
520 CARDIOGENIC SHOCK 129 0.0090
521 GAIT DISTURBANCE 1717 0.0090
522 DIZZINESS 4467 0.0089
523 WOUND INFECTION 98 0.0089
524 LIMB INJURY 243 0.0089
525 SEIZURE 1032 0.0089
526 PHOTOPHOBIA 168 0.0089
527 GASTROINTESTINAL HAEMORRHAGE 746 0.0089
528 DRUG INTOLERANCE 862 0.0089
529 ABNORMAL WEIGHT GAIN 110 0.0089
530 HEART RATE INCREASED 881 0.0089
531 CRYING 323 0.0089
532 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 632 0.0089
533 CEREBRAL HAEMORRHAGE 318 0.0089
534 EATING DISORDER 189 0.0089
535 ORAL HERPES 173 0.0089
536 CARPAL TUNNEL SYNDROME 124 0.0088
537 DRUG PRESCRIBING ERROR 170 0.0088
538 DEHYDRATION 1179 0.0088
539 DECUBITUS ULCER 72 0.0088
540 SQUAMOUS CELL CARCINOMA 83 0.0088
541 CHOLECYSTITIS 105 0.0088
542 DIVERTICULITIS 244 0.0088
543 FEELING HOT 539 0.0088
544 PAIN IN JAW 249 0.0088
545 MUSCULOSKELETAL STIFFNESS 770 0.0088
546 INTENTIONAL PRODUCT USE ISSUE 769 0.0088
547 INFUSION SITE ERYTHEMA 74 0.0088
548 RED BLOOD CELL COUNT DECREASED 250 0.0087
549 TOOTH ABSCESS 89 0.0087
550 GALLBLADDER DISORDER 156 0.0087
551 HYPOTHYROIDISM 279 0.0087
552 DENTAL CARIES 96 0.0087
553 NEURALGIA 211 0.0087
554 ARTHRITIS 682 0.0087
555 WEIGHT DECREASED 2419 0.0087
556 ABDOMINAL PAIN 2009 0.0086
557 MUSCULOSKELETAL PAIN 452 0.0086
558 PARAESTHESIA 1356 0.0086
559 MYOCARDITIS 98 0.0085
560 NERVE INJURY 95 0.0085
561 NECK PAIN 477 0.0085
562 SLUGGISHNESS 87 0.0085
563 TEMPERATURE INTOLERANCE 88 0.0085
564 BRONCHITIS 631 0.0085
565 CHEST DISCOMFORT 871 0.0085
566 OSTEOPENIA 129 0.0085
567 NERVOUSNESS 444 0.0085
568 PHARYNGEAL SWELLING 83 0.0085
569 FEEDING DISORDER 172 0.0085
570 CHEST PAIN 1569 0.0085
571 EMOTIONAL DISORDER 261 0.0085
572 HYPOAESTHESIA 1266 0.0084
573 PARAESTHESIA ORAL 122 0.0084
574 HEART RATE IRREGULAR 191 0.0084
575 PULMONARY EMBOLISM 801 0.0084
576 ILEUS 104 0.0084
577 SPLENOMEGALY 98 0.0084
578 ASTHENIA 3145 0.0084
579 HAEMORRHOIDS 163 0.0083
580 HEADACHE 5236 0.0083
581 FAECES DISCOLOURED 181 0.0083
582 DIARRHOEA HAEMORRHAGIC 78 0.0083
583 NERVE COMPRESSION 77 0.0083
584 DYSURIA 306 0.0083
585 MALNUTRITION 93 0.0083
586 DYSPHAGIA 789 0.0083
587 OVARIAN CYST 83 0.0083
588 CONDITION AGGRAVATED 2521 0.0083
589 SMALL INTESTINAL OBSTRUCTION 102 0.0083
590 WOUND 231 0.0083
591 DIABETES MELLITUS INADEQUATE CONTROL 146 0.0082
592 COLD SWEAT 145 0.0082
593 HAEMOPTYSIS 229 0.0082
594 ORAL CANDIDIASIS 108 0.0082
595 PULMONARY HYPERTENSION 170 0.0082
596 VOMITING 3836 0.0082
597 SCRATCH 86 0.0081
598 CYANOSIS 128 0.0081
599 ALANINE AMINOTRANSFERASE INCREASED 499 0.0081
600 LEUKOCYTOSIS 147 0.0081
601 BLOOD PRESSURE INCREASED 1235 0.0081
602 PULMONARY THROMBOSIS 88 0.0081
603 HYPERSENSITIVITY 1498 0.0081
604 CLOSTRIDIUM DIFFICILE INFECTION 176 0.0081
605 DECREASED APPETITE 1871 0.0080
606 BLOOD ALKALINE PHOSPHATASE INCREASED 200 0.0080
607 BLOOD TEST ABNORMAL 113 0.0080
608 FEELING JITTERY 153 0.0080
609 DRUG EXPOSURE DURING PREGNANCY 273 0.0080
610 HAIR TEXTURE ABNORMAL 107 0.0080
611 UPPER LIMB FRACTURE 159 0.0080
612 BLOOD TRIGLYCERIDES INCREASED 141 0.0080
613 GLOMERULAR FILTRATION RATE DECREASED 98 0.0080
614 TREATMENT NONCOMPLIANCE 435 0.0079
615 HEPATITIS 203 0.0079
616 OEDEMA PERIPHERAL 967 0.0079
617 PULMONARY MASS 118 0.0079
618 FEELING ABNORMAL 1895 0.0079
619 ANAEMIA 1502 0.0079
620 FRACTURE 149 0.0079
621 EAR PAIN 153 0.0079
622 MALAISE 3448 0.0079
623 WEIGHT FLUCTUATION 82 0.0078
624 VITREOUS FLOATERS 77 0.0078
625 SWELLING FACE 510 0.0078
626 COUGH 2195 0.0078
627 NEPHROLITHIASIS 359 0.0078
628 CELLULITIS 394 0.0078
629 PRODUCT PRESCRIBING ERROR 186 0.0078
630 PERIPHERAL SWELLING 1198 0.0078
631 ANGIOEDEMA 344 0.0078
632 SINUS CONGESTION 105 0.0078
633 ACUTE RESPIRATORY FAILURE 149 0.0077
634 NOCTURIA 94 0.0077
635 LIVER INJURY 190 0.0077
636 PHARYNGITIS 96 0.0077
637 ABDOMINAL DISTENSION 806 0.0077
638 HAEMOGLOBIN DECREASED 791 0.0077
639 PAIN IN EXTREMITY 2269 0.0077
640 PERICARDITIS 129 0.0077
641 TOOTHACHE 139 0.0077
642 NAUSEA 6075 0.0077
643 FLATULENCE 435 0.0077
644 PSORIASIS 1001 0.0077
645 COLITIS ULCERATIVE 342 0.0076
646 COAGULOPATHY 127 0.0076
647 STATUS EPILEPTICUS 86 0.0076
648 PARALYSIS 109 0.0076
649 KIDNEY INFECTION 149 0.0076
650 THYROID DISORDER 117 0.0076
651 PNEUMONIA 2448 0.0076
652 FISTULA 85 0.0076
653 DIARRHOEA 4873 0.0075
654 NO THERAPEUTIC RESPONSE 92 0.0075
655 ABDOMINAL DISCOMFORT 1265 0.0075
656 PYREXIA 2605 0.0075
657 FIBROMYALGIA 183 0.0075
658 INFLAMMATION 388 0.0075
659 ABDOMINAL PAIN LOWER 190 0.0075
660 TRANSAMINASES INCREASED 167 0.0075
661 PULMONARY FIBROSIS 144 0.0075
662 POLLAKIURIA 313 0.0075
663 ABDOMINAL PAIN UPPER 1540 0.0075
664 DYSPEPSIA 733 0.0074
665 OROPHARYNGEAL PAIN 688 0.0074
666 LYMPHOPENIA 105 0.0074
667 VIRAL INFECTION 247 0.0074
668 SEPSIS 827 0.0074
669 BLOOD CREATININE INCREASED 484 0.0074
670 INTESTINAL OBSTRUCTION 279 0.0074
671 DYSPNOEA 4187 0.0074
672 HYPERGLYCAEMIA 269 0.0074
673 BLOOD CHOLESTEROL INCREASED 344 0.0074
674 ARTHRALGIA 3067 0.0074
675 OEDEMA 400 0.0074
676 AGRANULOCYTOSIS 137 0.0074
677 PANCREATITIS 389 0.0074
678 LUNG DISORDER 360 0.0073
679 PHARYNGEAL OEDEMA 113 0.0073
680 ABSCESS 117 0.0073
681 TOOTH DISORDER 163 0.0073
682 SINUSITIS 751 0.0073
683 PAIN 4483 0.0073
684 HEPATIC FAILURE 220 0.0073
685 NASOPHARYNGITIS 1343 0.0073
686 PERIPHERAL COLDNESS 100 0.0073
687 CHOKING 142 0.0073
688 EJECTION FRACTION DECREASED 113 0.0073
689 LYMPHADENOPATHY 257 0.0073
690 PRURITUS GENERALISED 157 0.0073
691 C-REACTIVE PROTEIN INCREASED 264 0.0072
692 GASTROENTERITIS VIRAL 131 0.0072
693 DYSGEUSIA 538 0.0072
694 DIABETES MELLITUS 552 0.0072
695 HYPOAESTHESIA ORAL 109 0.0072
696 IMPAIRED DRIVING ABILITY 82 0.0072
697 RHINORRHOEA 466 0.0072
698 ATRIAL FIBRILLATION 701 0.0072
699 GASTROINTESTINAL PAIN 79 0.0072
700 ARTHROPATHY 399 0.0072
701 PREMATURE BABY 216 0.0072
702 CHILLS 841 0.0072
703 SKIN HAEMORRHAGE 106 0.0071
704 BASAL CELL CARCINOMA 111 0.0071
705 MYALGIA 1208 0.0071
706 GASTRIC DISORDER 243 0.0071
707 ACUTE RESPIRATORY DISTRESS SYNDROME 125 0.0071
708 SKIN INFECTION 79 0.0070
709 CARDIOMYOPATHY 104 0.0070
710 PRODUCT ADMINISTRATION ERROR 142 0.0070
711 BONE DISORDER 128 0.0070
712 APHONIA 98 0.0070
713 RESPIRATORY DISTRESS 193 0.0070
714 HOT FLUSH 527 0.0070
715 ROAD TRAFFIC ACCIDENT 291 0.0069
716 SNEEZING 156 0.0069
717 ANGINA PECTORIS 199 0.0069
718 BLOOD PRESSURE ABNORMAL 138 0.0069
719 EYE PRURITUS 233 0.0069
720 NASAL CONGESTION 405 0.0069
721 INFECTION 997 0.0069
722 SPINAL FRACTURE 138 0.0069
723 VISUAL IMPAIRMENT 851 0.0069
724 FLUSHING 698 0.0069
725 TREATMENT FAILURE 568 0.0068
726 CORONARY ARTERY OCCLUSION 94 0.0068
727 PANCREATITIS ACUTE 154 0.0068
728 LOCALISED INFECTION 165 0.0068
729 HERPES ZOSTER 392 0.0068
730 LOCAL SWELLING 119 0.0068
731 LIMB DISCOMFORT 211 0.0068
732 MADAROSIS 79 0.0068
733 COLITIS 258 0.0068
734 ASPARTATE AMINOTRANSFERASE INCREASED 360 0.0068
735 TARDIVE DYSKINESIA 190 0.0067
736 FLUID OVERLOAD 98 0.0067
737 MULTIPLE SCLEROSIS RELAPSE 461 0.0067
738 MUSCLE SPASMS 1233 0.0067
739 SCAR 115 0.0067
740 MULTI-ORGAN FAILURE 116 0.0067
741 MUSCLE ATROPHY 85 0.0067
742 JOINT INJURY 143 0.0067
743 CEREBRAL INFARCTION 163 0.0067
744 DYSPHONIA 389 0.0066
745 BLOOD URINE PRESENT 126 0.0066
746 UVEITIS 90 0.0066
747 ERYTHEMA 1364 0.0066
748 VISION BLURRED 911 0.0066
749 GASTROINTESTINAL DISORDER 594 0.0066
750 POST PROCEDURAL COMPLICATION 127 0.0066
751 HEPATIC CIRRHOSIS 124 0.0066
752 INFUSION SITE PAIN 85 0.0066
753 INFLUENZA 734 0.0066
754 HERNIA 127 0.0066
755 BEDRIDDEN 86 0.0065
756 BURNING SENSATION 457 0.0065
757 MULTIPLE FRACTURES 107 0.0065
758 PAIN OF SKIN 175 0.0065
759 HYPERTHYROIDISM 94 0.0065
760 RESPIRATORY TRACT INFECTION 169 0.0065
761 PERICARDIAL EFFUSION 150 0.0065
762 ROTATOR CUFF SYNDROME 83 0.0065
763 FEMUR FRACTURE 200 0.0065
764 FULL BLOOD COUNT DECREASED 130 0.0064
765 MULTIPLE SCLEROSIS 308 0.0064
766 GLOSSODYNIA 144 0.0064
767 DRY EYE 321 0.0064
768 SCHIZOPHRENIA 78 0.0064
769 SKIN LESION 176 0.0064
770 JAUNDICE 172 0.0064
771 NEUTROPHIL COUNT DECREASED 260 0.0064
772 CORONARY ARTERY DISEASE 193 0.0064
773 PLEURAL EFFUSION 387 0.0064
774 RESPIRATORY TRACT CONGESTION 101 0.0064
775 PRODUCT SUBSTITUTION ISSUE 366 0.0064
776 SKIN DISORDER 212 0.0063
777 ABASIA 157 0.0063
778 BLISTER 356 0.0063
779 DRUG WITHDRAWAL SYNDROME 554 0.0063
780 DISCOMFORT 385 0.0063
781 SARS-COV-2 TEST POSITIVE 83 0.0063
782 HEPATOCELLULAR INJURY 89 0.0063
783 ISCHAEMIC STROKE 112 0.0063
784 INFLUENZA LIKE ILLNESS 516 0.0063
785 SKIN ULCER 162 0.0063
786 BLOOD LACTATE DEHYDROGENASE INCREASED 99 0.0062
787 THROAT TIGHTNESS 169 0.0062
788 FACE OEDEMA 105 0.0062
789 SWELLING 581 0.0062
790 LOWER LIMB FRACTURE 119 0.0062
791 OSTEOMYELITIS 112 0.0062
792 RASH PRURITIC 335 0.0062
793 EPISTAXIS 462 0.0062
794 SHOCK 142 0.0062
795 CHOLESTASIS 118 0.0061
796 RASH GENERALISED 159 0.0061
797 ACUTE MYOCARDIAL INFARCTION 181 0.0061
798 COVID-19 1074 0.0061
799 INJURY 430 0.0061
800 CHROMATURIA 138 0.0061
801 PSORIATIC ARTHROPATHY 248 0.0061
802 SINUS DISORDER 121 0.0061
803 IRRITABLE BOWEL SYNDROME 131 0.0061
804 MUSCULOSKELETAL DISCOMFORT 105 0.0061
805 IMPAIRED HEALING 200 0.0061
806 RESPIRATORY DISORDER 182 0.0061
807 SKIN DISCOLOURATION 279 0.0061
808 BLOOD BILIRUBIN INCREASED 163 0.0060
809 STEVENS-JOHNSON SYNDROME 134 0.0060
810 ACUTE HEPATIC FAILURE 82 0.0060
811 HAEMATURIA 205 0.0060
812 NODULE 78 0.0060
813 ULCER 95 0.0060
814 CARDIAC FAILURE 479 0.0060
815 MATERNAL EXPOSURE DURING PREGNANCY 530 0.0059
816 TOOTH EXTRACTION 74 0.0059
817 BONE PAIN 348 0.0059
818 TASTE DISORDER 120 0.0059
819 THERAPEUTIC RESPONSE SHORTENED 196 0.0059
820 BONE DENSITY DECREASED 185 0.0059
821 MALIGNANT MELANOMA 79 0.0059
822 SKIN REACTION 83 0.0059
823 CYST 73 0.0059
824 RENAL IMPAIRMENT 493 0.0059
825 RASH 2556 0.0059
826 GOUT 105 0.0058
827 ADVERSE DRUG REACTION 525 0.0058
828 PRURITUS 2235 0.0058
829 WHITE BLOOD CELL COUNT DECREASED 629 0.0058
830 HAND DEFORMITY 76 0.0058
831 PRODUCT USE ISSUE 1089 0.0058
832 LUNG INFECTION 90 0.0058
833 BLINDNESS 236 0.0058
834 ECZEMA 303 0.0058
835 STAPHYLOCOCCAL INFECTION 190 0.0058
836 CENTRAL NERVOUS SYSTEM LESION 79 0.0057
837 HEPATOTOXICITY 128 0.0057
838 SKIN FISSURES 112 0.0057
839 GAIT INABILITY 191 0.0057
840 RASH PAPULAR 128 0.0057
841 URTICARIA 953 0.0057
842 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 97 0.0057
843 HYPOCALCAEMIA 107 0.0056
844 VAGINAL HAEMORRHAGE 244 0.0056
845 MUSCULOSKELETAL DISORDER 107 0.0056
846 TENDONITIS 87 0.0056
847 ALOPECIA 1101 0.0056
848 TOXIC EPIDERMAL NECROLYSIS 85 0.0056
849 NERVOUS SYSTEM DISORDER 173 0.0055
850 DERMATITIS 116 0.0055
851 LABORATORY TEST ABNORMAL 163 0.0055
852 NEUROPATHY PERIPHERAL 522 0.0055
853 PNEUMOTHORAX 87 0.0055
854 CEREBROVASCULAR ACCIDENT 927 0.0055
855 ORAL DISCOMFORT 76 0.0055
856 FUNGAL INFECTION 182 0.0055
857 PANCYTOPENIA 305 0.0055
858 EYE PAIN 307 0.0054
859 SYNOVITIS 98 0.0054
860 RASH MACULAR 190 0.0054
861 DIALYSIS 77 0.0054
862 GINGIVAL BLEEDING 74 0.0054
863 PRESCRIBED UNDERDOSE 108 0.0054
864 EYE SWELLING 200 0.0054
865 CATARACT 319 0.0054
866 GLAUCOMA 103 0.0053
867 BACTERIAL INFECTION 99 0.0053
868 SYSTEMIC LUPUS ERYTHEMATOSUS 187 0.0053
869 PROTEINURIA 100 0.0053
870 NEUTROPENIA 713 0.0052
871 VISUAL ACUITY REDUCED 174 0.0052
872 THROAT IRRITATION 235 0.0052
873 MASS 73 0.0052
874 ILLNESS 535 0.0052
875 AGEUSIA 129 0.0052
876 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 932 0.0052
877 FEBRILE NEUTROPENIA 343 0.0052
878 ASCITES 151 0.0051
879 LIVER DISORDER 227 0.0051
880 THERAPEUTIC RESPONSE UNEXPECTED 229 0.0051
881 ANAPHYLACTIC REACTION 282 0.0051
882 THROMBOSIS 409 0.0051
883 CARDIAC FAILURE CONGESTIVE 408 0.0051
884 EMOTIONAL DISTRESS 613 0.0051
885 OFF LABEL USE 4427 0.0051
886 BRONCHOSPASM 72 0.0050
887 MENORRHAGIA 99 0.0050
888 PLATELET COUNT DECREASED 536 0.0050
889 PRODUCT DOSE OMISSION 328 0.0050
890 DEAFNESS 131 0.0050
891 KNEE ARTHROPLASTY 105 0.0050
892 PERITONITIS 103 0.0050
893 DIABETIC KETOACIDOSIS 119 0.0049
894 RASH MACULO-PAPULAR 110 0.0049
895 BACK DISORDER 80 0.0049
896 STOMATITIS 298 0.0049
897 PELVIC PAIN 89 0.0049
898 PRODUCT USE IN UNAPPROVED INDICATION 1210 0.0049
899 ABORTION SPONTANEOUS 194 0.0048
900 INTENTIONAL DOSE OMISSION 138 0.0048
901 UNEVALUABLE EVENT 366 0.0048
902 PROCEDURAL PAIN 134 0.0048
903 ERUCTATION 93 0.0048
904 THERAPY NON-RESPONDER 216 0.0048
905 THERAPY CESSATION 246 0.0048
906 WRONG TECHNIQUE IN DRUG USAGE PROCESS 174 0.0048
907 HYPOACUSIS 206 0.0048
908 HIP ARTHROPLASTY 73 0.0048
909 LACRIMATION INCREASED 144 0.0048
910 NEUROTOXICITY 83 0.0047
911 DISEASE RECURRENCE 225 0.0047
912 DISABILITY 93 0.0047
913 CONJUNCTIVITIS 87 0.0047
914 EOSINOPHILIA 82 0.0047
915 CARDIAC DISORDER 427 0.0046
916 TOOTH LOSS 94 0.0045
917 CARDIOVASCULAR DISORDER 115 0.0045
918 DRUG-INDUCED LIVER INJURY 142 0.0045
919 PRODUCT DOSE OMISSION IN ERROR 128 0.0045
920 MYOCARDIAL INFARCTION 787 0.0045
921 LACTIC ACIDOSIS 146 0.0045
922 DRUG ADMINISTRATION ERROR 137 0.0045
923 DRUG DOSE OMISSION 734 0.0044
924 MULTIPLE ORGAN DYSFUNCTION SYNDROME 124 0.0044
925 HAEMORRHAGE 453 0.0043
926 EYE DISORDER 142 0.0043
927 GLYCOSYLATED HAEMOGLOBIN INCREASED 109 0.0043
928 ANAPHYLACTIC SHOCK 111 0.0043
929 DRUG INEFFECTIVE 5636 0.0043
930 RENAL DISORDER 199 0.0043
931 SEPTIC SHOCK 184 0.0042
932 PNEUMONITIS 115 0.0042
933 THERAPEUTIC PRODUCT EFFECT DECREASED 187 0.0042
934 BLOOD GLUCOSE ABNORMAL 77 0.0042
935 SURGERY 244 0.0042
936 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 295 0.0041
937 DRY SKIN 540 0.0040
938 BLOOD GLUCOSE INCREASED 760 0.0040
939 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 220 0.0040
940 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 103 0.0040
941 DRUG EFFECT DECREASED 211 0.0039
942 THERAPEUTIC RESPONSE DECREASED 234 0.0039
943 OSTEONECROSIS OF JAW 95 0.0038
944 PRODUCT AVAILABILITY ISSUE 86 0.0038
945 ILL-DEFINED DISORDER 229 0.0038
946 INTERSTITIAL LUNG DISEASE 182 0.0038
947 SKIN EXFOLIATION 314 0.0037
948 DEATH 3201 0.0037
949 PRODUCT PHYSICAL ISSUE 74 0.0037
950 LIVER FUNCTION TEST INCREASED 78 0.0036
951 MUCOSAL INFLAMMATION 95 0.0036
952 BLOOD GLUCOSE DECREASED 173 0.0036
953 DRUG EFFECT INCOMPLETE 129 0.0035
954 PRODUCT DOSE OMISSION ISSUE 1036 0.0035
955 PLASMA CELL MYELOMA 135 0.0035
956 INJECTION SITE MASS 126 0.0034
957 THERAPY INTERRUPTED 242 0.0034
958 DRUG DEPENDENCE 543 0.0034
959 DEVICE DISLOCATION 146 0.0034
960 OSTEONECROSIS 107 0.0033
961 DISEASE PROGRESSION 384 0.0032
962 LUNG NEOPLASM MALIGNANT 131 0.0032
963 INJECTION SITE BRUISING 252 0.0032
964 PRODUCT QUALITY ISSUE 419 0.0031
965 INCORRECT DOSE ADMINISTERED 702 0.0031
966 EYE IRRITATION 177 0.0031
967 MENSTRUATION IRREGULAR 82 0.0031
968 INJECTION SITE PRURITUS 205 0.0031
969 HOSPITALISATION 469 0.0030
970 UNDERDOSE 219 0.0030
971 NEOPLASM MALIGNANT 199 0.0030
972 INJECTION SITE REACTION 204 0.0030
973 DEVICE ISSUE 260 0.0029
974 INJECTION SITE ERYTHEMA 354 0.0029
975 OCULAR HYPERAEMIA 132 0.0028
976 ACNE 207 0.0027
977 INJECTION SITE SWELLING 207 0.0027
978 INJECTION SITE PAIN 812 0.0026
979 ADVERSE EVENT 240 0.0026
980 DERMATITIS ATOPIC 135 0.0026
981 NEOPLASM PROGRESSION 89 0.0026
982 MALIGNANT NEOPLASM PROGRESSION 261 0.0025
983 INJECTION SITE RASH 77 0.0025
984 SKIN BURNING SENSATION 174 0.0024
985 SKIN IRRITATION 109 0.0024
986 INJECTION SITE HAEMORRHAGE 186 0.0023
987 DEVICE MALFUNCTION 163 0.0023
988 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 457 0.0023
989 EXPIRED PRODUCT ADMINISTERED 72 0.0022
990 BREAST CANCER 192 0.0021
991 DEVICE BREAKAGE 81 0.0020
992 EXTRA DOSE ADMINISTERED 72 0.0018
993 ACCIDENTAL EXPOSURE TO PRODUCT 138 0.0013
994 NO ADVERSE EVENT 232 0.0013